Transposagen Overview
- Founded
-
2003

- Status
-
Acquired/Merged
- Employees
-
20

- Latest Deal Type
-
M&A
Transposagen General Information
Description
Developer of biotechnology drugs intended to improve drug discovery and development research. The company is biotechnology-based and provides genetically modified rat models to create improved preclinical models, performing cell engineering and in vitro and in vivo oncology studies for clients, enabling researchers to discover drugs and treat diseases.
Contact Information
Website
www.transposagenbio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 535 West Second Street
- Suite L102
- Lexington, KY 40508
- United States
Transposagen Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 01-Jan-2018 | 00.000 | Completed | Generating Revenue | ||
4. Grant | 21-Jun-2013 | 00.00 | 00.000 | Completed | Generating Revenue | |
3. Angel (individual) | 18-Jul-2012 | 00000 | 00.000 | Completed | Generating Revenue | |
2. Angel (individual) | 20-Dec-2011 | $725K | $725K | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Startup |
Transposagen Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of biotechnology drugs intended to improve drug discovery and development research. The company is biotechnolo
Biotechnology
Lexington, KY
20
As of 2015
00.000
000000&0
00.000
Transposagen Competitors (35)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Celyad Oncology | Formerly VC-backed | Mont-Saint-Guibert, Belgium | 000 | 00000 | 000000000 | 00000 |
00000 00000000000 | Formerly PE-Backed | Littleton, CO | 00 | 000000&0 | ||
000 00000000 | Corporation | Dublin, Ireland | ||||
0000000 0000000000 | Formerly VC-backed | Berkeley, CA | 000 | 00000 | 00000000 | 00000 |
0000000 00000000 | Venture Capital-Backed | Milpitas, CA | 00 | 000.00 | 0000000000 | 000.00 |
Transposagen Patents
Transposagen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2891510-C | Site-specific enzymes and methods of use | Active | 16-Nov-2012 | 0000000000 | |
ES-2778033-T3 | Site-specific enzymes and methods of use | Active | 16-Nov-2012 | 0000000000 | |
US-10844361-B2 | Site-specific enzymes and methods of use | Active | 16-Nov-2012 | 0000000000 | |
US-20200199553-A1 | Site-specific enzymes and methods of use | Active | 16-Nov-2012 | 0000000000 | |
US-20210062170-A1 | Site-specific enzymes and methods of use | Pending | 16-Nov-2012 | C07K14/195 |
Transposagen Signals
Transposagen Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 | ||
National Institutes of Health | Government | 000 0000 | 000000 0 |